Dexlansoprazole Impurity 4 - Request Quote
Dexlansoprazole Impurity 4
| SZ CAT No: | SZ-D086004 |
| CAS No | NA |
| Mol.F. | C31H25F3N6O2S |
| Mol.Wt. | 602.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dexlansoprazole Impurity 4 is chemically 12-(((1H-Benzo[d]imidazol-2-yl)thio)(4-methoxy-3-methylpyridin-2-yl)methyl)-1-methyl-2-(2,2,2-trifluoroethoxy)benzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridine. Dexlansoprazole Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Dexlansoprazole Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dexlansoprazole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Dexlansoprazole Impurity 4
Purchase Dexlansoprazole Impurity 4
Dexlansoprazole Impurity 4 suppliers
Dexlansoprazole Impurity 4 manufacturers
Dexlansoprazole Impurity 4 price
Order Dexlansoprazole Impurity 4
Enquire Dexlansoprazole Impurity 4
Dexlansoprazole Impurity 4 cost
Dexlansoprazole Impurity 4 Supplier
Dexlansoprazole Impurity 4 Distributor
Dexlansoprazole Impurity 4 for Method Validation
Dexlansoprazole Reference Standard
Dexlansoprazole Impurity 4 for ANDA Filing
Dexlansoprazole Impurity 4 for Forced Degradation Studies
Dexlansoprazole Impurity 4 Identification Standards
Dexlansoprazole Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.